{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:29:41Z","timestamp":1782386981311,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["CRC 1279 A03"],"award-info":[{"award-number":["CRC 1279 A03"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM135138"],"award-info":[{"award-number":["GM135138"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM067260"],"award-info":[{"award-number":["R01 GM067260"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jmb.2025.169007","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:25:00Z","timestamp":1739463900000},"page":"169007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum Amyloid A Binding to Glycosaminoglycans is Synergistic with Amyloid Formation: Therapeutic Targeting in the Inflammation-linked Amyloidosis"],"prefix":"10.1016","volume":"437","author":[{"given":"Shobini","family":"Jayaraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Urdaneta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Fandrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Gursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2025.169007_b0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2025.169007_b0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","article-title":"Serum amyloid A1: Structure, function and gene polymorphism","volume":"583","author":"Sun","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.jmb.2025.169007_b0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","article-title":"Serum amyloid A \u2013 a review","volume":"24","author":"Sack","year":"2018","journal-title":"Mol. Med."},{"key":"10.1016\/j.jmb.2025.169007_b0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/cmi.2015.97","article-title":"Hepatocytes: a key cell type for innate immunity","volume":"13","author":"Zhou","year":"2016","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.jmb.2025.169007_b0025","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2174\/0929867323666160418114600","article-title":"Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults","volume":"23","author":"De Buck","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jmb.2025.169007_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1197432","article-title":"Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions","volume":"10","author":"den Hartigh","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.jmb.2025.169007_b0035","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/1873-3468.12116","article-title":"Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks","volume":"590","author":"Frame","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jmb.2025.169007_b0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11883-020-00888-y","article-title":"Structural basis for vital function and malfunction of serum amyloid A: an acute-phase protein that wears hydrophobicity on its sleeve","volume":"22","author":"Gursky","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.jmb.2025.169007_b0045","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MOL.0000000000000616","article-title":"Role of serum amyloid A in atherosclerosis","volume":"30","author":"Shridas","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jmb.2025.169007_b0050","doi-asserted-by":"crossref","first-page":"E6507","DOI":"10.1073\/pnas.1707120114","article-title":"Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis","volume":"114","author":"Jayaraman","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169007_b0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(82)90321-X","article-title":"Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis","volume":"2","author":"De Beer","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2025.169007_b0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00428-001-0582-9","article-title":"Pathology, diagnosis and pathogenesis of AA amyloidosis","volume":"440","author":"R\u00f6cken","year":"2002","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jmb.2025.169007_b0065","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2025.169007_b0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020712-163913","article-title":"AA amyloidosis: pathogenesis and targeted therapy","volume":"10","author":"Westermark","year":"2015","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jmb.2025.169007_b0075","first-page":"1","article-title":"AA amyloidosis in vertebrates: epidemiology, pathology and molecular aspects","author":"Moccia","year":"2024","journal-title":"Amyloid"},{"key":"10.1016\/j.jmb.2025.169007_b0080","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/ATVBAHA.118.310979","article-title":"Serum amyloid A is an exchangeable apolipoprotein","volume":"38","author":"Wilson","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-319-17344-3_5","article-title":"Intrinsic stability, oligomerization, and amyloidogenicity of HDL-free serum amyloid A","volume":"855","author":"Col\u00f3n","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biochi.2014.05.007","article-title":"Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A","volume":"104","author":"Aguilera","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.jmb.2025.169007_b0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13506129.2016.1168292","article-title":"Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A","volume":"23","author":"Takase","year":"2016","journal-title":"Amyloid"},{"key":"10.1016\/j.jmb.2025.169007_b0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/13506120601116419","article-title":"Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications","volume":"14","author":"Kisilevsky","year":"2007","journal-title":"Amyloid"},{"key":"10.1016\/j.jmb.2025.169007_b0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fmolb.2016.00017","article-title":"Historical and current concepts of fibrillogenesis and in vivo amyloidogenesis: implications of amyloid tissue targeting","volume":"3","author":"Kisilevsky","year":"2016","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jmb.2025.169007_b0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10719-017-9769-4","article-title":"Sulfated glycosaminoglycans in protein aggregation diseases","volume":"34","author":"Nishitsuji","year":"2017","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jmb.2025.169007_b0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0295-143","article-title":"Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer\u2019s disease","volume":"1","author":"Kisilevsky","year":"1995","journal-title":"Nature Med."},{"key":"10.1016\/j.jmb.2025.169007_b0120","first-page":"665","article-title":"Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis","volume":"56","author":"Snow","year":"1987","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jmb.2025.169007_b0125","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/39.10.1940305","article-title":"A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis","volume":"39","author":"Snow","year":"1991","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.jmb.2025.169007_b0130","doi-asserted-by":"crossref","first-page":"E586","DOI":"10.1073\/pnas.1103247108","article-title":"In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides","volume":"108","author":"Wall","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169007_b0135","doi-asserted-by":"crossref","first-page":"25669","DOI":"10.1074\/jbc.M112.363895","article-title":"Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation","volume":"287","author":"Noborn","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2025.169007_b0140","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1073\/pnas.0502287102","article-title":"In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis","volume":"102","author":"Li","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169007_b0145","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1096\/fj.09-134981","article-title":"Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch","volume":"23","author":"Elimova","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.jmb.2025.169007_b0150","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa065644","article-title":"Eprodisate for AA Amyloidosis Trial Group, Eprodisate for the treatment of renal disease in AA amyloidosis","volume":"356","author":"Dember","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2025.169007_b0155","first-page":"37","article-title":"Review of eprodisate for the treatment of renal disease in AA amyloidosis","volume":"5","author":"Rumjon","year":"2012","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"10.1016\/j.jmb.2025.169007_b0160","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.3390\/molecules20022510","article-title":"The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity","volume":"20","author":"Iannuzzi","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jmb.2025.169007_b0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-030-70115-4_9","article-title":"Glycosaminoglycans in neurodegenerative diseases","volume":"1325","author":"Jin","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0170","first-page":"120","article-title":"Sulfated glycosaminoglycans: a common constituent of all amyloids?","volume":"56","author":"Snow","year":"1987","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jmb.2025.169007_b0175","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1021\/bi101905n","article-title":"Heparin binds 8 kDa gelsolin cross-\u03b2-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension","volume":"50","author":"Solomon","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2025.169007_b0180","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1073\/pnas.1101194108","article-title":"Heparan sulfate\/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein","volume":"108","author":"Noborn","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169007_b0185","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/bi101822y","article-title":"Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion","volume":"50","author":"Bourgault","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2025.169007_b0190","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jmb.2017.07.003","article-title":"Molecular origins of the compatibility between glycosaminoglycans and A\u03b240 amyloid fibrils","volume":"429","author":"Stewart","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0195","doi-asserted-by":"crossref","first-page":"13234","DOI":"10.1073\/pnas.1810058115","article-title":"Cofactors are essential constituents of stable and seeding-active tau fibrils","volume":"115","author":"Fichou","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169007_b0200","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/978-3-030-34521-1_25","article-title":"Implications of heparan sulfate and heparanase in amyloid diseases","volume":"1221","author":"Li","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0205","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jb\/mvp128","article-title":"Amyloid formation by the model protein muscle acylphosphatase is accelerated by heparin and heparan sulphate through a scaffolding-based mechanism","volume":"146","author":"Motamedi-Shad","year":"2009","journal-title":"J. Biochem."},{"key":"10.1016\/j.jmb.2025.169007_b0210","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.tibs.2021.05.003","article-title":"Protein amyloid cofactors: charged side-chain arrays meet their match?","volume":"46","author":"Lewkowicz","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jmb.2025.169007_b0215","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","article-title":"A new era for understanding amyloid structures and disease","volume":"19","author":"Iadanza","year":"2018","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0220","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1016\/j.cell.2021.08.013","article-title":"The expanding amyloid family: structure, stability, function, and pathogenesis","volume":"184","author":"Sawaya","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2025.169007_b0225","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41467-019-09033-z","article-title":"Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids","volume":"10","author":"Liberta","year":"2019","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2025.169007_b0230","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1038\/s41467-022-34636-4","article-title":"Amyloid fibril structure from the vascular variant of systemic AA amyloidosis","volume":"13","author":"Banerjee","year":"2022","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2025.169007_b0235","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1038\/s41467-022-34743-2","article-title":"Cryo-EM structure of ex vivo fibrils associated with extreme AA amyloidosis prevalence in a cat shelter","volume":"13","author":"Schulte","year":"2022","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2025.169007_b0240","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1038\/s41467-022-31790-7","article-title":"Heparin induces \u03b1-synuclein to form new fibril polymorphs with attenuated neuropathology","volume":"13","author":"Tao","year":"2022","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2025.169007_b0245","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/acs.biochem.4c00529","article-title":"Elucidating the mechanism of recognition and binding of heparin to amyloid fibrils of serum amyloid A","volume":"64","author":"Abraham","year":"2025","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2025.169007_b0250","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.1322357111","article-title":"Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis","volume":"111","author":"Lu","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169007_b0255","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","article-title":"Amyloid oligomers: a joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s disease, type II diabetes, and amyotrophic lateral sclerosis","volume":"121","author":"Nguyen","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmb.2025.169007_b0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/01913123.2013.861568","article-title":"Extrusion of amyloid fibrils to the extracellular space in experimental mesangial AL-amyloidosis: transmission and scanning electron microscopy studies and correlation with renal biopsy observations","volume":"38","author":"Teng","year":"2014","journal-title":"Ultrastruct. Pathol."},{"issue":"Pt 1","key":"10.1016\/j.jmb.2025.169007_b0265","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/bj2880225","article-title":"Isolation and partial characterization of heparan sulphate proteoglycans from human hepatic amyloid","volume":"288","author":"Magnus","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.jmb.2025.169007_b0270","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1218297","article-title":"Unravelling the interplay between extracellular acidosis and immune cells","volume":"2018","author":"Erra D\u00edaz","year":"2018","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.jmb.2025.169007_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100451","article-title":"LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery","volume":"64","author":"Jayaraman","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jmb.2025.169007_b0280","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1194\/jlr.M059162","article-title":"Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL","volume":"56","author":"Jayaraman","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jmb.2025.169007_b0285","series-title":"Lipids in protein misfolding","first-page":"117","article-title":"Intrinsic stability, oligomerization, and amyloidogenicity of HDL-free serum amyloid A","author":"Col\u00f3n","year":"2015"},{"key":"10.1016\/j.jmb.2025.169007_b0290","doi-asserted-by":"crossref","first-page":"e4983","DOI":"10.1002\/pro.4983","article-title":"Structural studies of a serum amyloid A octamer that is primed to scaffold lipid nanodiscs","volume":"33","author":"Nady","year":"2024","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmb.2025.169007_b0295","first-page":"255","article-title":"Temperature-induced dissociation of serum amyloid protein SAA","volume":"155","author":"Linke","year":"1979","journal-title":"Z. Immunitatsforsch. Immunobiol."},{"key":"10.1016\/j.jmb.2025.169007_b0300","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.sbi.2021.11.004","article-title":"Unveiling induced folding of intrinsically disordered proteins \u2013 protein engineering, frustration and emerging themes","volume":"72","author":"Malagrin\u00f2","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0305","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1073\/pnas.1910713116","article-title":"Molecular basis for retinol binding by serum amyloid A during infection","volume":"116","author":"Hu","year":"2019","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2025.169007_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100429","article-title":"Lipid clearance and amyloid formation by serum amyloid A: exploring the links between beneficial and pathologic actions of an enigmatic protein","volume":"64","author":"Jayaraman","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jmb.2025.169007_b0315","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jsb.2017.06.007","article-title":"Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a \u201cmolecular mop\u201d in immune response","volume":"200","author":"Frame","year":"2017","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102678","article-title":"Role of aberrant phase separation in pathological protein aggregation","volume":"82","author":"Chakraborty","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0325","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/aca.aca_117_23","article-title":"Protamine and heparin interactions: a narrative review","volume":"27","author":"Crivellari","year":"2024","journal-title":"Ann. Card Anaesth."},{"key":"10.1016\/j.jmb.2025.169007_b0330","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.jmb.2018.08.016","article-title":"Polyphosphate stabilizes protein unfolding intermediates as soluble amyloid-like oligomers","volume":"430","author":"Yoo","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002650","article-title":"Amyloid accelerator polyphosphate fits as the mystery density in \u03b1-synuclein fibrils","volume":"22","author":"Huettemann","year":"2024","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jmb.2025.169007_b0340","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41467-022-28765-z","article-title":"Phase separation on cell surface facilitates bFGF signal transduction with heparan sulphate","volume":"13","author":"Xue","year":"2022","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2025.169007_b0345","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1038\/s41467-024-50686-2","article-title":"Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis","volume":"15","author":"Schulte","year":"2024","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2025.169007_b0350","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1039\/D4BM00816B","article-title":"Molecular basis for non-invasive diagnostics of cardiac amyloids using bone tracers","volume":"12","author":"Lewkowicz","year":"2024","journal-title":"Biomater. Sci."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283625000737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283625000737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:13:29Z","timestamp":1741626809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283625000737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0022283625000737"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2025.169007","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Amyloid A Binding to Glycosaminoglycans is Synergistic with Amyloid Formation: Therapeutic Targeting in the Inflammation-linked Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2025.169007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"169007"}}